Nancy Twine’s return to hair care provides a useful look at what happens legally before a beauty product launch reaches consumers. The Briogeo founder is preparing to launch Soulstice, a new hair care brand scheduled to begin direct-to-consumer sales on September 1, 2026, with products positioned around accessible pricing, science-backed formulation, and a more premium beauty experience.
Behind the launch, however, is a legal strategy that began years earlier. Public records show trademark filings, portfolio expansion, a corporate entity established well before launch, and two active Trademark Trial and Appeal Board proceedings involving the Soulstice brand and one of its product names. For founders preparing a beauty product launch, hair care product launch, or cosmetics brand launch, the timeline illustrates why intellectual property, FDA requirements, product claims, and manufacturing arrangements should be addressed before packaging and marketing are finalized.
Soulstice Built Its Beauty Trademark Portfolio Before Going to Market
Twine founded Briogeo in 2013 and later sold the company to Wella Company in 2022. Her next beauty business has been developing more quietly. Soulstice Hair Care, LLC was formed in Florida in May 2023, while trademark activity surrounding the SOULSTICE name dates back even further.
An early SOULSTICE federal trademark application was filed in July 2020 for shampoos, conditioners, hair oils, styling products, sprays, and related goods. That application ultimately registered in May 2024. More recent filings show a broader portfolio developing around names including VITAMEGA, BUTTERSILK, MOISTURE MUSE, FEATHERLIFT, BASE LAYER, WAVELENGTH, SCIENCE MEETS SOUL, and HAIRCARE FOR YOUR HIGHEST SELF.
That approach reflects an important distinction in beauty brand trademark protection. A company’s intellectual property may extend well beyond its primary brand name. Product names, proprietary ingredient complexes, slogans, collections, and other source-identifying elements can develop independent value and may require separate clearance and protection.
Soulstice’s launch lineup demonstrates the point. Reported products include Moisture Muse Shampoo and Conditioner and the ButterSilk Restorative Mask, while the formulations use a proprietary VitaMega complex containing kakadu plum, inositol, and sacha inchi. Several names consumers will encounter at launch therefore correspond with marks that have already been incorporated into the company’s trademark strategy.
Soulstice Trademark Disputes Show Why Beauty Brand Clearance Cannot End With Filing
Advance filing reduces uncertainty, but it does not eliminate trademark disputes. Soulstice is approaching launch while participating on both sides of proceedings before the USPTO’s Trademark Trial and Appeal Board.
On August 19, 2026, Rolanda Bell filed an opposition against Soulstice Hair Care, LLC’s newer SOULSTICE application, Serial No. 99500073. The opposition identifies rights associated with SOULSTICE BEAUTY, SOULSTICE BEAUTY NETWORK, and SOULSTICE NATURAL HAIR AND BEAUTY EXPO. The proceeding is pending as Opposition No. 91309785.
Soulstice is also pursuing a challenge of its own. On June 25, 2026, it initiated Cancellation No. 92092075 against Butter Silk LLC’s federal registration for BUTTER SILK. Soulstice has separately sought protection for BUTTERSILK, which is being used in connection with the reported ButterSilk Restorative Mask.
Neither proceeding determines, by itself, whether Soulstice can use the respective marks in commerce. TTAB proceedings generally concern federal registration rights rather than deciding infringement or issuing injunctions against marketplace use. But the disputes demonstrate why trademark clearance for cosmetics and hair care brands should account for more than identical names.
A launch may involve a house mark, product names, technology names, slogans, packaging elements, and future product extensions. Each can create separate clearance questions. For founders investing in formulation, packaging, inventory, influencer campaigns, and retail placement, discovering a trademark problem after those expenditures have been made can make a naming dispute considerably more expensive.
FDA Cosmetics Rules Put Hair Growth and Scalp Claims Under Scrutiny
Soulstice is being positioned around the intersection of science and personal care. Its VitaMega complex and reported messaging concerning hydration, strength, scalp vitality, and long-term hair health illustrate another legal issue facing modern beauty companies: the language used to sell a product can affect how regulators view it.
FDA distinguishes cosmetics from drugs based in part on intended use. A shampoo marketed to cleanse or beautify hair can qualify as a cosmetic. Claims that a product restores hair growth, treats disease, or affects the structure or function of the body can instead cause the product to be regulated as a drug. FDA specifically identifies hair-restoration claims as an example of language capable of changing a product’s regulatory classification.
This creates an important drafting issue for a hair care product launch. Words such as “repair,” “strengthen,” “restore,” “scalp health,” and similar science-oriented terminology must be assessed in context. Packaging, website descriptions, before-and-after content, social media, and influencer statements can collectively communicate more than the company intended.
FTC advertising principles create a related substantiation issue. Objective product claims must have an adequate basis before advertising is published, and health-related claims generally require competent and reliable scientific evidence. The FTC also evaluates implied claims and the overall impression created by advertising.
The often-overlooked legal gap concerns ingredient evidence versus finished-product claims. Research showing that an individual ingredient possesses certain characteristics does not automatically establish that a finished shampoo, mask, or styling product delivers the same advertised benefit. The FTC expressly advises marketers to consider whether studies actually correspond to the formulation, dosage, method of use, and benefit being advertised.
For beauty founders, claims review therefore belongs in product development rather than at the end of the marketing process.
strategic by design: The Juris Law Group Perspective
Launching a cosmetics or hair care company now requires coordination between brand protection and a more developed federal cosmetics framework. Under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), covered manufacturers and processors must register cosmetic facilities with FDA and renew those registrations every two years. Responsible persons must list marketed cosmetic products, including ingredients, and update product listings annually. Responsible persons also have safety substantiation and serious adverse-event reporting responsibilities, subject to applicable exemptions.
Cosmetic labeling adds another layer. Products distributed in the United States must comply with FDA requirements under the FD&C Act and Fair Packaging and Labeling Act, including applicable identity, net quantity, and ingredient-declaration requirements. Retail cosmetics generally must identify ingredients by their common or usual names and list them in descending order of predominance, subject to applicable rules and exceptions.
Our cosmetics attorneys assess these issues as interconnected parts of commercialization. We identify and clear the brand and product names while the regulatory analysis addresses formulation, labeling, claims, MoCRA obligations, and advertising. Manufacturing, co-packing, confidentiality, distribution, influencer, and retailer agreements can then allocate the commercial risks surrounding the product.
The same approach applies beyond beauty. Whether counsel is advising on hair care, skin care, apparel, supplements, food, beverages, or other consumer goods, the objective is to build the legal structure around how the company will actually manufacture, market, and sell the product. Our approach remains consistent with the firm’s philosophy: Bigger is not better, better is better®.
What Beauty Founders Should Address Before Going to Market
Over the next 12 months, Soulstice’s commercial growth will unfold alongside its trademark proceedings and the continued expansion of its brand portfolio. Its September launch will also test how its science-oriented positioning translates from pre-launch coverage into actual packaging, digital advertising, consumer reviews, influencer content, and future product extensions. Those channels can create both additional intellectual property and additional advertising exposure.
For the broader beauty industry, the lesson extends beyond one company. Launching a consumer brand increasingly requires founders to make legal decisions while the product is still being developed: who owns the formula, whether the proposed name is available, which product names merit separate trademark protection, what evidence supports performance claims, whether packaging satisfies FDA requirements, and which party carries responsibility under manufacturing and distribution agreements. The strongest launch strategy treats those questions as part of commercialization rather than as cleanup after the product enters the market.
Common Legal Inquiries
When should a beauty brand file a trademark application?
Ideally, trademark clearance should occur before a company commits substantial resources to its name, packaging, website, inventory, or marketing. Depending on the circumstances, an intent-to-use application can allow a beauty company to seek federal protection before commercial sales begin, giving the founder greater visibility into potential registration issues while the product is being developed.
What FDA requirements apply when launching a hair care product?
The requirements depend on the product, claims, business size, and manufacturing structure. Cosmetics may be subject to FDA labeling requirements and MoCRA provisions concerning facility registration, product listing, safety substantiation, adverse-event reporting, and other obligations. Claims that cross into therapeutic or structure/function territory can also change the product’s regulatory status.
Can a beauty brand advertise an ingredient as “science-backed”?
Potentially, but the supporting evidence must match the representation being made. FTC principles require objective claims to have adequate substantiation before dissemination. Evidence about an ingredient does not necessarily prove that the finished cosmetic delivers the same result, particularly where concentration, formulation, application, or study conditions differ from the marketed product.
